Marksans Pharma Ltd

BSE: 524404

22

total announcements

MARKSANS.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 16 Oct 2026

Market Cap

₹13,968 Cr

P/E (TTM)

39.7

P/E (Forward)

29.8

EPS (TTM)

₹7.76

52W Low

₹157.25

52W High

₹314.25

Dividend Yield

0.45%

Beta

1.07

Price / Book

5.2

Return on Equity

14.07%

Debt / Equity

12.2

Revenue (TTM)

₹2,731 Cr

Gross Margin

54.29%

Operating Margin

16.32%

BSECompany Update30 Jul 2026

Marksans Pharma Ltd

Newspaper Publication for AGM Intimation

Marksans Pharma Ltd has published a newspaper advertisement regarding the 34th Annual General Meeting scheduled to be held on August 27, 2026, through VC/OAVM facility.

Read more →📎 1 attachment
BSECompany Update23 Jun 2026

Marksans Pharma Ltd

Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF

Marksans Pharma Ltd has initiated a 'Saksham Niveshak' campaign, a second 100-day drive, following guidance from the Ministry of Corporate Affairs (MCA). The campaign aims to assist shareholders in updating their KYC details, registering nominations, and claiming unclaimed dividends from Financial Year 2018-19 onwards. This proactive measure seeks to prevent these unclaimed dividends from being transferred to the Investor Education and Protection Fund (IEPF). Shareholders are encouraged to contact the Company's Registrar and Transfer Agent (RTA) or Company Secretary for assistance before the deadline of July 08, 2026.

Read more →📎 1 attachment
← PreviousPage 2 of 2